Long-Term Patient-Reported Outcomes after Multiport Robot-Assisted Surgery versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study.
TL;DR
Compared with M-VATS, RATS offers perioperative advantages, including reduced symptoms and better clinical outcomes, but at higher costs, while U-VATS enhanced lymph-node dissection rates but increased postoperative cough and slowed HRQoL recovery.
OpenAlex 토픽 ·
Lung Cancer Diagnosis and Treatment
Lung Cancer Research Studies
Hepatocellular Carcinoma Treatment and Prognosis
Compared with M-VATS, RATS offers perioperative advantages, including reduced symptoms and better clinical outcomes, but at higher costs, while U-VATS enhanced lymph-node dissection rates but increase
- p-value P = 0.017
- p-value P = 0.049
- 연구 설계 cohort study
APA
Xing Wei, Hongfan Yu, et al. (2026). Long-Term Patient-Reported Outcomes after Multiport Robot-Assisted Surgery versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study.. Annals of surgical oncology, 33(5), 4288-4300. https://doi.org/10.1245/s10434-025-18834-0
MLA
Xing Wei, et al.. "Long-Term Patient-Reported Outcomes after Multiport Robot-Assisted Surgery versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study.." Annals of surgical oncology, vol. 33, no. 5, 2026, pp. 4288-4300.
PMID
41665783
Abstract
[BACKGROUND] The purpose of this study was to compare patient-reported outcomes (PROs) and perioperative clinical outcomes during 1 year post surgery between robot-assisted thoracoscopic surgery (RATS) and video-assisted thoracoscopic surgery (VATS), including multiportal (M-VATS) and uniportal (U-VATS) approaches, in patients with lung cancer.
[METHODS] Data from a prospective cohort study (CN-PRO-Lung3) were analyzed, and patients with primary lung cancer who underwent RATS or VATS were included. Primary outcomes were postoperative symptoms and daily functioning assessed using the Perioperative Symptom Assessment (PSA)-Lung, and exploratory outcomes included health-related quality of life (HRQoL) based on the Five-Level EuroQol Five-Dimensional Questionnaire and other clinical outcomes. Propensity score matching (PSM) was adjusted for baseline differences.
[RESULTS] After the PSM of 687 patients, 91 patients were matched between RATS and M-VATS and 119 between RATS and U-VATS. Compared with those undergoing M-VATS, patients undergoing RATS reported lower rates of moderate-to-severe fatigue (P = 0.017) and disturbed sleep (P = 0.049) in the hospital. Additionally, RATS demonstrated better clinical outcomes, including more lymph-node dissections (P < 0.001), less blood loss (P < 0.001), shorter operative time (P < 0.001), and reduced hospital stays (P < 0.001) than M-VATS but incurred higher costs (P < 0.001). Compared with those undergoing U-VATS, patients undergoing RATS reported higher rates of moderate-to-severe cough (P = 0.007) and slower initial HRQoL recovery after discharge.
[CONCLUSIONS] Compared with M-VATS, RATS offers perioperative advantages, including reduced symptoms and better clinical outcomes, but at higher costs. Compared with U-VATS, RATS enhanced lymph-node dissection rates but increased postoperative cough and slowed HRQoL recovery. This study highlights the importance of incorporating PROs into surgical decision-making. Clinical registration ChiCTR2000033016 ( https://www.chictr.org.cn/searchprojEN.html ).
[METHODS] Data from a prospective cohort study (CN-PRO-Lung3) were analyzed, and patients with primary lung cancer who underwent RATS or VATS were included. Primary outcomes were postoperative symptoms and daily functioning assessed using the Perioperative Symptom Assessment (PSA)-Lung, and exploratory outcomes included health-related quality of life (HRQoL) based on the Five-Level EuroQol Five-Dimensional Questionnaire and other clinical outcomes. Propensity score matching (PSM) was adjusted for baseline differences.
[RESULTS] After the PSM of 687 patients, 91 patients were matched between RATS and M-VATS and 119 between RATS and U-VATS. Compared with those undergoing M-VATS, patients undergoing RATS reported lower rates of moderate-to-severe fatigue (P = 0.017) and disturbed sleep (P = 0.049) in the hospital. Additionally, RATS demonstrated better clinical outcomes, including more lymph-node dissections (P < 0.001), less blood loss (P < 0.001), shorter operative time (P < 0.001), and reduced hospital stays (P < 0.001) than M-VATS but incurred higher costs (P < 0.001). Compared with those undergoing U-VATS, patients undergoing RATS reported higher rates of moderate-to-severe cough (P = 0.007) and slower initial HRQoL recovery after discharge.
[CONCLUSIONS] Compared with M-VATS, RATS offers perioperative advantages, including reduced symptoms and better clinical outcomes, but at higher costs. Compared with U-VATS, RATS enhanced lymph-node dissection rates but increased postoperative cough and slowed HRQoL recovery. This study highlights the importance of incorporating PROs into surgical decision-making. Clinical registration ChiCTR2000033016 ( https://www.chictr.org.cn/searchprojEN.html ).
MeSH Terms
Humans; Lung Neoplasms; Thoracic Surgery, Video-Assisted; Patient Reported Outcome Measures; Male; Quality of Life; Female; Robotic Surgical Procedures; Prospective Studies; Aged; Middle Aged; Follow-Up Studies; Postoperative Complications; Prognosis; Pneumonectomy
같은 제1저자의 인용 많은 논문 (5)
- Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.
- ASO Author Reflections: Balancing Robotic Technology, Incision Strategy, and Patient Experience in Lung Cancer Surgery.
- ASO Visual Abstract: Long-Term Patient-Reported Outcomes After Multiport Robot-Assisted Surgery Versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study.
- LDHA-driven lactate metabolism promotes MDSC activation and immunosuppressive microenvironment in prostate cancer.
- Response to commentary: Dissecting domain-specific cognitive gains of Baduanjin exercise in breast cancer patients receiving chemotherapy.